Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
148.19
-16.43 (-9.98%)
At close: Jan 2, 2026, 4:00 PM EST
147.41
-0.78 (-0.53%)
After-hours: Jan 2, 2026, 7:26 PM EST
Nutex Health Revenue
Nutex Health had revenue of $267.80M in the quarter ending September 30, 2025, with 239.87% growth. This brings the company's revenue in the last twelve months to $981.20M, up 87.14% year-over-year. In the year 2024, Nutex Health had annual revenue of $479.95M.
Revenue (ttm)
$981.20M
Revenue Growth
+87.14%
P/S Ratio
1.00
Revenue / Employee
$1,226,495
Employees
800
Market Cap
1.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 479.95M | - | - |
| Dec 31, 2023 | 479.95M | 232.30M | 93.80% |
| Dec 31, 2022 | 247.65M | 28.35M | 12.93% |
| Dec 31, 2021 | 219.29M | -54.73M | -19.97% |
| Dec 31, 2020 | 274.03M | 272.66M | 19,954.54% |
| Dec 31, 2019 | 1.37M | -577.00 | -0.04% |
| Dec 31, 2018 | 1.37M | 1.34M | 5,800.87% |
| Dec 31, 2017 | 23.17K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 1.46M | -132.70K | -8.33% |
| Dec 31, 2012 | 1.59M | -190.02K | -10.65% |
| Dec 31, 2011 | 1.78M | 909.13K | 103.93% |
| Dec 31, 2010 | 874.77K | 701.76K | 405.62% |
| Dec 31, 2009 | 173.01K | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NUTX News
- 11 days ago - NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS - PRNewsWire
- 22 days ago - NUTX Investors Have Opportunity to Join Nutex Health Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 4 weeks ago - NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN - PRNewsWire
- 4 weeks ago - Nutex Health Inc. (NUTX) Discusses Restated 2024 Results and Combined Second and Third Quarter 2025 Financial Performance Transcript - Seeking Alpha
- 4 weeks ago - Nutex Health: Fairly Valued After Pullback, But Wait For A More Ideal Entry Point (Rating Upgrade) - Seeking Alpha
- 5 weeks ago - NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT - PRNewsWire
- 5 weeks ago - NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS - PRNewsWire
- 6 weeks ago - NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS - PRNewsWire